Physician
Elite Pediatrics LLC
Elite Pediatrics LLC was paid $3.82M by Medicaid between Jan 2018 and Nov 2024, across 67 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 56% of everything it billed.
33Billing provider infoELITE PEDIATRICS LLC
ELMWOOD PARK, NJ 07407
ELMWOOD PARK, NJ 07407
33aNPI1588107874assigned 11/18/2016
33bProvider typePediatrics Physician
28Total paid$3.82M
24GClaims102,643
24DCodes billed67
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other Pediatrics Physician providers in New Jersey
Rank by total paid#36 of 549
Median peer was paid$154K
This provider vs. median25×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 4,115 | $176K | |
| 2019 | 8,316 | $306K | |
| 2020 | 12,123 | $440K | |
| 2021 | 15,600 | $639K | |
| 2022 | 25,573 | $856K | |
| 2023 | 19,576 | $718K | |
| 2024incomplete | 17,340 | $685K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 56% | 32,135 | 25,791 | $2.14M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 9.6% | 4,036 | 3,732 | $368K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 7.2% | 3,068 | 2,979 | $277K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 5.9% | 2,785 | 2,667 | $225K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 5.8% | 9,716 | 9,284 | $221K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 2.4% | 1,028 | 1,015 | $91K |
| 90677 | 2.3% | 590 | 573 | $87K | |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 1.7% | 681 | 668 | $66K |
| 90461 | 1.6% | 3,931 | 3,766 | $60K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 1,013 | 938 | $37K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 2,985 | 2,913 | $26K |
| 92551 | <1% | 3,140 | 2,741 | $22K |
55 more codes
| S0302 | Completed early periodic screening diagnosis and treatment (epsdt) service (list in addition to code for appropriate evaluation and management service) | <1% | 4,004 | $20K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 1,385 | $15K |
| 97802 | <1% | 2,105 | $14K | |
| 90670 | <1% | 1,314 | $14K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 288 | $12K |
| 99381 | <1% | 173 | $10K | |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 119 | $10K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 509 | $9K |
| 90651 | <1% | 317 | $9K | |
| 90686 | <1% | 3,888 | $8K | |
| 99460 | <1% | 156 | $7K | |
| 96127 | <1% | 1,519 | $7K | |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 46 | $6K |
| 99239 | Hospital discharge day management, more than 30 minutes | <1% | 97 | $6K |
| 99383 | <1% | 65 | $6K | |
| 99051 | <1% | 3,004 | $4K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 316 | $4K |
| 36415 | Collection of venous blood by venipuncture | <1% | 1,369 | $4K |
| 90698 | <1% | 1,176 | $3K | |
| 99238 | Hospital discharge day management, 30 minutes or less | <1% | 55 | $3K |
| 99442 | <1% | 88 | $3K | |
| 83655 | <1% | 1,029 | $3K | |
| 90734 | <1% | 141 | $3K | |
| 90680 | <1% | 927 | $2K | |
| 90633 | <1% | 932 | $2K | |
| 90710 | <1% | 109 | $2K | |
| 99401 | <1% | 78 | $2K | |
| 36406 | <1% | 139 | $2K | |
| 36410 | <1% | 203 | $2K | |
| 99462 | <1% | 51 | $1K | |
| 96160 | <1% | 1,734 | $1K | |
| 94664 | <1% | 115 | $1K | |
| 96161 | <1% | 2,312 | $1K | |
| 81000 | <1% | 644 | $992.29 | |
| 90716 | <1% | 155 | $760.11 | |
| 90744 | <1% | 723 | $675.77 | |
| 0071A | <1% | 16 | $645.85 | |
| 36400 | <1% | 26 | $491.38 | |
| 94760 | <1% | 759 | $415.83 | |
| 99000 | <1% | 4,319 | $365.51 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 71 | $343.97 |
| 90707 | <1% | 139 | $311.88 | |
| 90700 | <1% | 103 | $301.04 | |
| 90715 | <1% | 61 | $234.48 | |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 14 | $232.83 |
| 90696 | <1% | 99 | $161.83 | |
| A7003 | Administration set, with small volume nonfiltered pneumatic nebulizer, disposable | <1% | 133 | $142.71 |
| 92558 | <1% | 16 | $134.05 | |
| 90647 | <1% | 107 | $122.13 | |
| 90648 | <1% | 45 | $88.76 | |
| J7620 | Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | <1% | 102 | $86.97 |
| 91307 | <1% | 38 | $11.00 | |
| 99070 | <1% | 56 | $2.00 | |
| 99072 | 0% | 126 | $0.00 | |
| 99461 | 0% | 20 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialRAMADI, ROULA (MD/OWNER)